Frédérique Maindrault‐Gœbel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A multicenter, open-label, noncomparative, randomized phase II study (PEPCOL) was conducted to evaluate the efficacy and safety of the irinotecan or PEP02 (MM-398, nanoliposomal irinotecan) with(More)
  • 1